When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set ...
The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...
The drugs are 10 times more dangerous than fentanyl. They are showing up in street drugs in the South and the Midwest, and ...
Tennessee is moving forward with clinical trials of ibogaine, a controversial psychedelic drug recently fast-tracked for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results